Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

BACKGROUND: Single agent immune checkpoint inhibitors (ICIs) improve survival outcomes compared to chemotherapy for advanced non‐small cell lung cancer (NSCLC), but treatment efficacy widely varies. The combination of ICIs with chemotherapy has shown promising efficacy over chemotherapy alone; howev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Kuo, Chih‐Hsi Scott, Wang, Chin‐Chou, Huang, Yu‐Chen, Pavlidis, Stelios, Liu, Chien‐Ying, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Wang, Chih‐Liang, Guo, Yi‐Ke, Yang, Cheng‐Ta
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501017/
https://ncbi.nlm.nih.gov/pubmed/30950239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados